---
title: "Lixte Biotechnology files initial beneficial ownership statement for director John Travaglini"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291572343.md"
description: "Lixte Biotechnology Holdings Inc. filed an initial Form 3 with the SEC on July 1, 2026, designating John Francis Travaglini as a director and disclosing his beneficial ownership."
datetime: "2026-07-02T16:52:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291572343.md)
  - [en](https://longbridge.com/en/news/291572343.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291572343.md)
generator: "portal-rs"
---

# Lixte Biotechnology files initial beneficial ownership statement for director John Travaglini

-   Lixte Biotechnology named John Francis Travaglini as a director in an initial Form 3 filing dated July 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lixte Biotechnology Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031723), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LIXT.US](https://longbridge.com/en/quote/LIXT.US.md)

## Related News & Research

- [First Breach files Form 3 showing director Robert Charles Brandt stake of 34,247 shares](https://longbridge.com/en/news/298649951.md)
- [AdaptHealth files Form 3 showing CFO Harriss T. Currie as beneficial owner](https://longbridge.com/en/news/298765282.md)
- [Interactive Strength files Form 3 showing Thomas Barclay Aulet stake of 791,735 shares](https://longbridge.com/en/news/298598501.md)
- [Zenas BioPharma files Form 3 showing InnoCare Pharma stake of 7 million shares](https://longbridge.com/en/news/298305393.md)
- [Super Hi International files Form 3 initial beneficial ownership statement for CFO Li Lu](https://longbridge.com/en/news/298301990.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**